Dr. George Anastassov, MD, DDS, MBA, Director
- Founder of AXIM Biotechnologies.
During his tenure as the President, CEO and Chairman of the Board he propelled the company from a market capitalization of $10 mln to over $1 bln. within a period of less than two years.
AXIM was named as one of the top 5 performing biotech stocks for 2016 by Fox Business News
- Co-founder, Board Member and a general partner of Sanammad Foundation and Sanammad Pharmaceuticals, BV
- Co-founder and the CEO of CanChew Biotechnologies, LLC
- Possesses Medical and Dental Doctorates as well as an Executive MBA
